BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35273734)

  • 1. Pars plana vitrectomy assisted by intravitreal injection of conbercept enhances the therapeutic effect and quality of life in patients with severe proliferative diabetic retinopathy.
    Wang Q; Cai H; Xu D; Cui L; Zhang Y; Chen M
    Am J Transl Res; 2022; 14(2):1324-1331. PubMed ID: 35273734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intravitreal Conbercept Injection on Complications of Pars Plana Vitrectomy in Patients with Proliferative Diabetic Retinopathy.
    Ding Y; Su N; Luan J; Ni Y; Sun Z
    J Pers Med; 2023 Mar; 13(4):. PubMed ID: 37108958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravitreal conbercept treatment before vitrectomy in proliferative diabetic retinopathy.
    Mao JB; Wu HF; Chen YQ; Zhao SX; Tao JW; Zhang Y; Zheng B; Wang L; Shen LJ
    Int J Ophthalmol; 2018; 11(7):1217-1221. PubMed ID: 30046542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Conbercept Injection as an Adjuvant in Vitrectomy with Silicone Oil Infusion for Severe Proliferative Diabetic Retinopathy.
    Gao S; Lin Z; Chen Y; Xu J; Zhang Q; Chen J; Shen X
    J Ocul Pharmacol Ther; 2020 Jun; 36(5):304-310. PubMed ID: 32186940
    [No Abstract]   [Full Text] [Related]  

  • 5. Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy.
    Wang W; Qu C; Yan H
    Front Endocrinol (Lausanne); 2023; 14():1098165. PubMed ID: 36896181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.
    Jiang T; Gu J; Zhang P; Chen W; Chang Q
    BMC Ophthalmol; 2020 Feb; 20(1):43. PubMed ID: 32013913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy.
    Cui J; Chen H; Lu H; Dong F; Wei D; Jiao Y; Charles S; Gu W; Wang L
    J Ophthalmol; 2018; 2018():4927259. PubMed ID: 30046459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of angiogenic factors in aqueous humor associated with less intraoperative bleeding in PDR patients with NVG receiving conbercept: a randomized controlled trial.
    Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Yang L; Fan W; Guan L; Li J; Zhang Y; Li S
    BMC Ophthalmol; 2022 May; 22(1):224. PubMed ID: 35585570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraocular pharmacokinetics of anti-vascular endothelial growth factor agents by intraoperative subretinal versus intravitreal injection in silicone oil-filled eyes of proliferative diabetic retinopathy: a randomized controlled pilot study.
    Yao TT; Yang Y; Jin XL; Wang YX; Zhou YL; Xu AJ; He FL; Wang ZY
    Acta Ophthalmol; 2020 Nov; 98(7):e795-e800. PubMed ID: 32114709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy.
    Li B; Li MD; Ye JJ; Chen Z; Guo ZJ; Di Y
    Chin Med J (Engl); 2020 Mar; 133(6):664-669. PubMed ID: 32068603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the adjuvant effect of conbercept intravitreal injection at different times before vitrectomy for proliferative diabetic retinopathy.
    Yang Z; Di Y; Ye J; Yu W; Guo Z
    Front Endocrinol (Lausanne); 2023; 14():1171628. PubMed ID: 37305048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Randomized Controlled Trial of Conbercept Pretreatment before Vitrectomy in Proliferative Diabetic Retinopathy.
    Yang X; Xu J; Wang R; Mei Y; Lei H; Liu J; Zhang T; Zhao H
    J Ophthalmol; 2016; 2016():2473234. PubMed ID: 27034822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Use of Anti-VEGF Drugs Before and During Pars Plana Vitrectomy for Severe Proliferative Diabetic Retinopathy.
    Sun X; Wang X; Guo X; Wang M; Liu H
    Ophthalmol Ther; 2023 Dec; 12(6):3133-3142. PubMed ID: 37713065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy.
    Hu L; Chen Q; Du Z; Wang W; Zhao G
    Int Ophthalmol; 2021 May; 41(5):1635-1642. PubMed ID: 33538931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients.
    Xu Y; Xie C; Fang Y; Yu Y; Qiu C
    Int J Ophthalmol; 2022; 15(10):1619-1626. PubMed ID: 36262859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal conbercept as an adjuvant in vitrectomy for proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.
    Chen GH; Tzekov R; Mao SH; Tong YH; Jiang FZ; Li WS
    Eye (Lond); 2022 Mar; 36(3):619-626. PubMed ID: 33824510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Intravitreal Conbercept Facilitates Vitrectomy in Proliferative Diabetic Retinopathy: Is Attention Required for the Fellow Eye?
    Xu W; Cheng W; Yao Y; Guo J; Xu G
    J Ophthalmol; 2019; 2019():2923950. PubMed ID: 31467691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial.
    Li S; Guo L; Zhou P; Tang J; Wang Z; Zhang L; Zhao M; Qu J
    Eye Vis (Lond); 2022 Dec; 9(1):44. PubMed ID: 36451252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Bevacizumab Injection before Vitrectomy on Intravitreal Hemorrhage in Pseudophakic Patients with Proliferative Diabetic Retinopathy.
    Demir M; Oba E; Can E; Kara O; Cinar S
    Ophthalmol Eye Dis; 2013; 5():11-5. PubMed ID: 23926440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy.
    Guan J; Cai N; Liu LM; Zhao N; Liu NN
    Diabetes Ther; 2020 Jun; 11(6):1397-1406. PubMed ID: 32356244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.